Benjamin Vieten

Benjamin Vieten

Auto-generated profile, based on publicly available information

Benjamin Vieten

Department of Hematology and Oncology, University Cancer Center Schleswig‐Holstein (UCCSH), University Hospital Schleswig‐Holstein (UKSH) University of Luebeck Luebeck Germany

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2026 in Clinical Case Reports
Verified
Journal Article
Open access
BVBenjamin Vieten
Benjamin Vieten
JVJan Vorwerk
Jan Vorwerk
JMJan Morf
Jan Morf
ADAlice Dauth
Alice Dauth
SSStefan Sondermann
Stefan Sondermann
CKCyrus Khandanpour
Cyrus Khandanpour
Sickle cell disease (SCD) with hemoglobin‐ (Hb‐) SC genotype is often considered a milder SCD variant, yet life‐threatening complications can occur. A 26‐year‐old man with HbSC disease presented with an infection triggered vaso‐occlusive crisis (VOC), acute chest syndrome (ACS), severe thrombocytopenia, Coombs‐negative hemolysis with schistocytes, acute kidney injury, and markedly elevated lactate dehydrogenase (LDH) in the setting of Klebsiella pneumoniae sepsis. The resulting severe thrombotic microangiopathy‐ (TMA‐) like phenotype initially raised concern for thrombotic thrombocytopenic purpura (TTP). However, ADAMTS13 activity was not significantly reduced, arguing against classical TTP. The episode was interpreted as a TTP‐like syndrome, whereas fat embolism syndrome (FES) remained an important differential diagnosis. The patient received red‐cell exchange, plasma exchange, caplacizumab, antibiotics, and dialysis, followed by hematologic and renal recovery. Months later, he developed a non‐aneurysmal infratentorial subarachnoid hemorrhage (SAH) with obstructive hydrocephalus requiring external ventricular drainage (EVD) and posterior fossa decompression, resulting in severe persistent neurological disability. The case, therefore, highlights the severity of HbSC disease and the challenge of urgent treatment decisions under substantial diagnostic uncertainty when a TMA‐like presentation overlaps with other severe SCD complications such as FES.